Social Capital Hedosophia Holdings Corporation III (NYSE:IPOC) shareholders approved its business combination with Medicaid insurer Clover Health at a special meeting earlier today.
The company said in a press release that 65% of shares participated in the vote and about 99.5% voted in favor of the deal. Social Capital III initially announced its $3.7 billion deal with Clover Health on October 6. Clover is the fastest-growing private insurer covering members through the Medicaid Advantage program.
The parties aim to close the transaction tomorrow, January 7, which will be the last day Social Capital III will trade on the NYSE. The combined entity’s shares and warrants are then to transfer to the Nasdaq and trade under the ticker symbols “CLOV” and “CLOVW,” respectively beginning January 8.
Clover CEO Vivek Garipalli told CNBC at the time of the deal announcement that the company was initially set on an IPO track in early 2020. But, uncertainty about potential healthcare policy changes under a new administration made a SPAC-listing an easier path. That political change is now a reality, but has not dampened market enthusiasm for Clover as it opened at $15.39 ahead of the vote.
This was a significantly more confident trading value that Social Capital I (NYSE:SPCE) had going into the morning of its approval vote for Virgin Galactic in 2019, which opened at $10.62 at the time. But, the Clover transaction for now remains the market’s second favorite Chamath Palihapitiya SPAC production, with Social Capital II’s (NYSE:OPEN) deal with OpenDoor opening at $26.69 ahead of its December 17 approval vote and now trades above $27.
Terms Tracker for the Week Ending June 20, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Two more SPACs priced IPOs this week, one each from Cohen and Cantor. That brings June’s IPO count to five and the 2025 year-to-date tally...
CSLM Digital Asset (NASDAQ:KOYNU) has filed for a $200 million IPO to hunt for a crypto transaction with a team that includes veterans from a variety of other SPAC efforts. The new SPAC sports 1/2 warrants in units and will have 24 months to initially close a business combination. It becomes the 16th SPAC that...
At the SPAC of Dawn The past year has seen a string of serial sponsor teams return to market, with some already listing multiple vehicles in a full return to the hunt. One prolific SPAC leader that has been conspicuously absent from this return so far has been Chamath Palihapitiya, who has been a part...
BM Acquisition Corp. (NASDAQ:BMOKU) has filed for a $60 million IPO to bring another first-time, Asia-based team to the market. The new SPAC is serving up 1/2 warrants in each of its units and the team will have 18 months under its initial search window to close a deal. It may extend this, but only...
At the SPAC of Dawn The Fed’s rate decision day has finally come and futures are slightly green in anticipation. De-SPACs have largely opted not to hedge their bets on the event with several making large-scale equity capital raises directly on its eve. Four companies alone raised over $1 billion in secondary offerings this week,...